Status:
WITHDRAWN
Phytoestrogens and Breast Cancer - Effects of Phytoestrogens on Markers of Disease Progression and Gene Expression
Lead Sponsor:
Danish Cancer Society
Collaborating Sponsors:
Rigshospitalet, Denmark
Conditions:
Breast Cancer
Breast Neoplasms
Eligibility:
FEMALE
18-99 years
Phase:
NA
Brief Summary
The aim is to investigate if soy isoflavones and lignans affect markers of disease progression and gene expression among breast cancer patients receiving neo-adjuvant treatment in a three arm, double-...
Eligibility Criteria
Inclusion
- Diagnosed with breast cancer at "Brystkirurgisk Afdeling" at Rigshospitalet and Herlev Hospitals (within the last 30 days).
- Advised (and accepted) to receive neo-adjuvant treatment
- Primary unilateral breast cancer
- Treatment is expected to be curative
- Is expected to be able to attend surgery
Exclusion
- Allergic to soy
- Celiac disease
- Inflammatory bowel disease
- Not understanding Danish (patient material and questionnaires are in Danish)
- Prior diagnosis of breast cancer
- Use of dietary supplements containing lignans or isoflavones three months prior to diagnosis
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04880369
Start Date
March 1 2021
End Date
December 1 2022
Last Update
August 7 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.